Inventory of oral anticancer agents: pharmaceutical formulation aspects with focus on the solid dispersion technique by Sawicki, E, Schellens, J.H.M, Beijnen, J.H, Nuijen, B

Get full text

Validation and clinical application of an LC-MS/MS method for the quantification of everolimus using volumetric absorptive microsampling by Verheijen, R.B., Thijssen, B., Atrafi, F., Schellens, J.H.M., Rosing, H., de Vries, N., Beijnen, J.H., Mathijssen, R.H.J., Steeghs, N., Huitema, A.D.R.

Get full text

420 INVITED Innovative Models to Optimize Phase I Development of Novel Anticancer Agents by Schellens, J.H.M

Get full text

Bioanalysis of ibrutinib, and its dihydrodiol- and glutathione cycle metabolites by liquid chromatography-tandem mass spectrometry by Rood, J.J.M., Dormans, P.J.A., van Haren, M.J., Schellens, J.H.M., Beijnen, J.H., Sparidans, R.W.

Get full text

Development and validation of a high-performance liquid chromatography–tandem mass spectrometry assay quantifying olaparib in human plasma by Nijenhuis, C.M., Lucas, L., Rosing, H., Schellens, J.H.M., Beijnen, J.H.

Get full text

Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001) by Moes, J.J., Koolen, S.L.W., Huitema, A.D.R., Schellens, J.H.M., Beijnen, J.H., Nuijen, B.

Get full text

The role of nuclear receptors in pharmacokinetic drug–drug interactions in oncology by Harmsen, S, Meijerman, I, Beijnen, J.H, Schellens, J.H.M

Get full text

Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis by Devriese, L.A, Bosma, A.J, van de Heuvel, M.M, Heemsbergen, W, Voest, E.E, Schellens, J.H.M

Get full text

Effect of Chinese herbs on CYP3A4 activity and expression in vitro by Lau, C., Mooiman, K.D., Maas-Bakker, R.F., Beijnen, J.H., Schellens, J.H.M., Meijerman, I.

Get full text

Development and validation of LC–MS/MS assays for the quantification of E7080 and metabolites in various human biological matrices by Dubbelman, A.C., Rosing, H., Thijssen, B., Gebretensae, A., Lucas, L., Chen, H., Shumaker, R., Schellens, J.H.M., Beijnen, J.H.

Get full text

Development and validation of LC–MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine by Dubbelman, A.C., Tibben, M., Rosing, H., Gebretensae, A., Nan, L., Gorman, S.H., Robertson, P., Schellens, J.H.M., Beijnen, J.H.

Get full text

Liquid chromatography-tandem mass spectrometry assay for the quantification of niraparib and its metabolite M1 in human plasma and urine by van Andel, L., Zhang, Z., Lu, S., Kansra, V., Agarwal, S., Hughes, L., Tibben, M.M., Gebretensae, A., Rosing, H., Schellens, J.H.M., Beijnen, J.H.

Get full text

Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with... by Teunissen, S.F., Jager, N.G.L., Rosing, H., Schinkel, A.H., Schellens, J.H.M., Beijnen, J.H.

Get full text

Bioanalytical methods for determination of tamoxifen and its phase I metabolites: A review by Teunissen, S.F., Rosing, H., Schinkel, A.H., Schellens, J.H.M., Beijnen, J.H.

Get full text

351 Sensitive pharmacodynamic assessment of PARP inhibitors for individualized treatment in clinic by Haan, R. De, Pluim, D, Van Triest, B, Verheij, M, Schellens, J.H.M, Vens, C

Get full text

Characterization of Absorption, Metabolism, and Elimination of Niraparib, an Investigational Poly (ADP-Ribose) Polymerase Inhibitor, in Cancer Patients by Zhang, Z.-Y, Kansra, V, van Andel, L, Tibben, M.M, Rosing, H, Lu, S, Agarwal, S, Hughes, L, Schellens, J.H.M, Beijnen, J.H

Get full text

Quantification of cabazitaxel, its metabolite docetaxel and the determination of the demethylated metabolites RPR112698 and RPR123142 as docetaxel equivalents in human plasma by li... by Kort, A., Hillebrand, M.J.X., Cirkel, G.A., Voest, E.E., Schinkel, A.H., Rosing, H., Schellens, J.H.M., Beijnen, J.H.

Get full text

Improvement of Oral Drug Treatment by Temporary Inhibition of Drug Transporters and/or Cytochrome P450 in the Gastrointestinal Tract and Liver: An Overview by Kruijtzer, C.M.F., Beijnen, J.H., Schellens, J.H.M.

Get full text

Is combination therapy the next step to overcome resistance and reduce toxicities in melanoma? by Nijenhuis, C.M, Haanen, J.B.A.G, Schellens, J.H.M, Beijnen, J.H

Get full text

Future opportunities in preventing cisplatin induced ototoxicity by van den Berg, J.H., Beijnen, J.H., Balm, A.J.M., Schellens, J.H.M.

Get full text